Compositions for lessening oxidative stress
View Patent ↗The present invention provides an antioxidative composition with high safety, which is capable of lessening oxidative stress due to active oxygen species, free radicals, or the like in vivo, thereby preventing the occurrence or worsening of a disease. It was confirmed that by using a composition containing oxidized coenzyme Q and/or reduced coenzyme Q, the amount of urinary 8-hydroxydeoxyquanosine can be decreased in normal or diabetic animals. Also, in histopathological research of the spleens of diabetic rats, it was confirmed that spleen tissue denaturation caused by oxidative stress can be prevented. It was thus found that oxidative stress in vivo can be lessened. According to the present invention, oxidative stress in vivo can be lessened by using a composition containing coenzyme Q as an active ingredient.
1. A composition for lessening oxidative stress, comprising, as an active ingredient, coenzyme Q represented by formula (1) and formula (2), the coenzyme Q of formula (2) being present in an amount of 0.1% by weight to 0.5% by weight, based on the weight of the composition:
(wherein n represents an integer from 1 to 12);
(wherein n represents an integer from 1 to 12).
2. The composition according to claim 1 , wherein the coenzyme Q of formula (1) and (2) is coenzyme Q 10 .
3. A method for lessening oxidative stress in vivo in a subject in need thereof, comprising administering to said subject a composition containing a reduced coenzyme Q of formula (2) and an oxidized coenzyme Q of formula (1), he coenzyme Q of formula (2) being present in an amount of 0.1% by weight to 0.5% by weight, based on the weight of the composition:
(wherein n represents an integer from 1 to 12);
(wherein n represents an integer from 1 to 12).
4. A method for reducing oxidative stress associated with a disease in vivo comprising administering to a subject a composition containing a reduced coenzyme Q antioxidant of formula (2) and an oxidized coenzyme Q of formula (1), the coenzyme Q of formula (2) being present in an amount of 0.1% by weight to 0.5% by weight, based on the weight of the composition:
(wherein n represents an integer from 1 to 12);
(wherein n represents an integer from 1 to 12).
5. A method for according to claim 4 , wherein the disease is selected from the group consisting of cerebral ischemia, hepatopathy, diabetes, nervous diseases, renal diseases, hepatic cirrhosis, arthritis, retinopathy of prematurity, ocular uveitis, retinal rust disease, senile cataract, asbestos diseases, bronchial failures due to smoking, cerebral edema, pulmonary edema, foot edema, cerebral infarction, hemolytic anemia, progeria, epilepsy, Behect's disease, Crohn's disease, Kawasaki disease, Weber-Christian disease, collagen disease, progressive systemic sclerosis, herpetic dermatitis and immune deficiency syndrome.
6. A method according to claim 4 , wherein the reduced and oxidized coenzyme Q are administered to a human in a total dose per kg of weight of a human body of 0.1 mg/day to 500 mg/day.
7. A method according to claim 4 , wherein the reduced and oxidized coenzyme Q are administered to a human in a total dose per kg of weight of a human body of 1 mg/day to 100 mg/day.
8. A method according to claim 4 , wherein the reduced and oxidized coenzyme Q are administered to a human in a total dose per kg of weight of a human body of 2 mg/day to 75 mg/day.
9. A method for reducing oxidative stress in vivo due to a skin disease comprising externally administering to a subject a composition containing a reduced coenzyme Q of formula (2) and an oxidized coenzyme Q of formula (1) the coenzyme Q of formula (2) being present in an amount of 0.1% by weight to 0.5% by weight, based on the weight of the composition:
(wherein n represents an integer from 1 to 12);
(wherein n represents an integer from 1 to 12).
10. A method for lessening oxidative stress in vivo in a subject in need thereof, comprising administering to said subject a composition containing a reduced coenzyme Q of formula (2), the coenzyme Q of formula (2) being present in an amount of 0.1% by weight to 0.5% by weight, based on the weight of the composition:
(wherein n represents an integer from 1 to 12).
11. A method for reducing oxidative stress in vivo due to a skin disease comprising administering to a subject a composition containing a reduced coenzyme Q antioxidant of formula (2), the coenzyme Q of formula (2) being present in an amount of 0.1% by weight to 0.5% by weight, based on the weight of the composition:
(wherein n represents an integer from 1 to 12).
12. A method according to claim 11 , wherein the disease is selected from the group consisting of cerebral ischemia, hepatopathy, diabetes, nervous diseases, renal diseases, hepatic cirrhosis, arthritis, retinopathy of prematurity, ocular uveitis, retinal rust disease, senile cataract, asbestos diseases, bronchial failures due to smoking, cerebral edema, pulmonary edema, foot edema, cerebral infarction, hemolytic anemia, progeria, epilepsy, Behect's disease, Crohn's disease, Kawasaki disease, Weber-Christian disease, collagen disease, progressive systemic sclerosis, herpetic dermatitis and immune deficiency syndrome.
13. A method according to claim 11 , wherein the reduced coenzyme Q is administered to a human in dose per kg of weight of a human body of 0.1 mg/day to 500 mg/day.
14. A method according to claim 11 , wherein the reduced coenzyme Q is administered to a human in dose per kg of weight of a human body of 1 mg/day to 100 mg/day.
15. A method according to claim 11 , wherein the reduced coenzyme Q is administered to a human in dose per kg of weight of a human body of 2 mg/day to 75 mg/day.
16. A method for reducing oxidative stress due to a skin disease in vivo comprising externally administering to a subject a composition containing a reduced coenzyme Q of formula (2), the coenzyme Q of formula (2) being present in an amount of 0.1% by weight to 0.5% by weight, based on the weight of the composition:
(wherein n represents an integer from 1 to 12).